Latest filingAug 28, 2026Most recent Form 4
BSEM
BioStem Technologies, Inc.
NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$00 sells
Net open-market+$07 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period14transactions
- M · Option exercise · dominant14 · 100%
Activity by reported role
A joint filing can contribute to multiple roles14transactions
- Director · dominant10 · 71%
- CAO2 · 14%
- Chief financial officer2 · 14%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (7)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeFortunato Michael ARestricted Stock Units · Direct
6,790Aug 09, 2026
Fortunato Michael ACommon Stock · Direct
64,430Aug 09, 2026
Poe BrandonRestricted Stock Units · Direct
21,591Aug 11, 2026
Poe BrandonCommon Stock · Direct
56,368Aug 11, 2026
Sonenreich Steven DRestricted Stock Units · Direct
0Aug 27, 2026
Sonenreich Steven DCommon Stock · Direct
7,671Aug 27, 2026
Warrington Kenneth Howard JrRestricted Stock Units · Direct
0Aug 27, 2026
Warrington Kenneth Howard JrCommon Stock · Direct
32,234Aug 27, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- PB+$0
- FA+$0
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
BSEM transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| BSEM | POE BRANDON | CFO | exercise | 10.6k | $0 | M | −4.9% | 08/20 | 08/11 | |
| BSEM | POE BRANDON | CFO | exercise | 10.6k | $0 | M | −4.9% | 08/20 | 08/11 | |
| BSEM | FORTUNATO MICHAEL A | CAO | exercise | 970 | $0 | M | −4.9% | 08/20 | 08/09 | |
| BSEM | FORTUNATO MICHAEL A | CAO | exercise | 970 | $0 | M | −4.9% | 08/20 | 08/09 |
BioStem Technologies, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at BioStem Technologies, Inc.?
UNGRODT JODI, Glickman Mark A, LESSER HANNAWAY RAYNA, WARRINGTON KENNETH HOWARD JR, SONENREICH STEVEN D, POE BRANDON, FORTUNATO MICHAEL A.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
No code-P purchases or code-S sales were reported in the selected period.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.